Clinical Features

It is Time to Change How We Manage Mild Asthma

Written by Dr Aoife O’Reilly & Professor Eleanor Dunican. Patients with infrequent asthma symptoms can suffer severe/ mild asthma attacks.

It is Time to Change How We Manage Mild Asthma

PDF article · 124.4 KB Available in full to verified members — read it online or download it.

Management of mild asthma has traditionally relied on inhaled corticosteroid (ICS) used regularly for asthma control. This is as well as inhaled short-acting beta agonist (SABA) used as needed for symptom relief. In 2019, the Global Initiative for Asthma (GINA) made a fundamental change to its recommendations for the treatment of asthma. GINA no longer recommends regular use of SABA as a reliever without an ICS.

For verified healthcare professionals

Log in or register for free to read this article. HPN is for healthcare professionals, so new accounts are verified by our team.

Register for free Log in

Join the conversation

Comments are open to registered members. Log in or register to share your thoughts on this article.

Log in to comment Register for free